Researches are beginning preparations for the first human trials of synthetic blood cells, produced in a laboratory. These trials should happen within the next two years; and they are beginning of one the most significant medical developments in recent history.
Dr Nick Watkins, from the University of Cambridge, is the NHS Blood and Transplant Assistant Director of Research and Development. He describes: “Scientists across the globe have been investigating for a number of years how to manufacture red blood cells to offer an alternative to donated blood to treat patients. We are confident that by 2017 our team will be ready to carry out the first early phase clinical trials in human volunteers.”
Furthermore, Dr. Watkins attests, “These trials will compare manufactured cells with donated blood. The intention is not to replace blood donation but provide specialist treatment for specific patient groups.”
Yes, that is important to remember: this project is not intended to replace human blood. However, the development will provide more options for patients in desperate need of healthy blood. Perhaps synthetic blood is not a permanent solution but it may also provide health workers with a stop gap measure that can give doctors more time to treat a patient.
Indeed, he says, “Research has laid the foundation for current transfusion and transplantation practices. Continued investment in research and development is critical to our role in saving and improving lives through blood and organ donation. Our five-year research and development plan will ensure we advance treatment of all who depend upon our products and services.”
He also goes on to explain that “The manufactured red cell trials form part of our world-leading work in regenerative medicine and one of eight research goals for 2015-2020 that will bring long-term improvements for patients and donors.”
Hiç yorum yok:
Yorum Gönder